Document is current
Any future updates will be listed below
-
Authors
Lin, Feng Bin
Da Chen, Shi
Song, Yun He
Wang, Wei
Jin, Ling
Liu, Bing Qian
Liu, Yu Hong
Chen, Mei Ling
Gao, Kai
Friedman, David S.
Jonas, Jost B.
Aung, Tin
Lv, Lin
Liu, Yi Zhi
Zhang, Xiu Lan https://orcid.org/0000-0002-9288-0767
,
Zhang, Xiu Lan
Liu, Yi Zhi
Lv, Lin
Friedman, David S.
Jonas, Jost B.
Aung, Tin
Da Chen, Shi
Wang, Wei
Lin, Feng Bin
Song, Yun He
Li, Fei
Gao, Kai
Liu, Bing Qian
Liu, Yu Hong
Chen, Mei Ling
Bressler, Neil M.
Park, Ki Ho
He, Ming Guang
Cheng, Ching-yu
Healey, Paul
Chen, Xiang
Tang, Guang Xian
Jin, Ling
-
Funding
Funding for this research was provided by:
High-level Hospital Construction Project, Zhongshan Ophthalmic Center, Sun Yat-sen University (303020104)
- License Information
-
More Information
Article History
Received: 22 April 2020
Accepted: 17 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: The study adheres to the tenets of the Declaration of Helsinki. Ethical approval was granted by the Ethics Committee of the Zhongshan Ophthalmic Center, Sun Yat-sen University, China (ID: 2020KYPJ026). The trial is monitored by a trial management group, a trial SC, and a DMC.Participants meeting the diagnosis of GSHM will be invited to enroll in the study and receive a patient information leaflet with all the details of the trial and their screening appointment reminder letter. On attending the screening clinic, they will be approached by a trained research coordinator to establish whether they wish to participate in the trial. If they express their interest, the researcher will take written informed consent and enrolls them into the trial. If an individual subsequently requests to be withdrawn from the trial, this individual will revert to the standard care. Reasons for withdrawal will be noted.
: These are available from the corresponding author upon request.
: The authors declare that they have no competing interests.
